Board of Directors

Elisabeth Maurer

Dr. Elisabeth Maurer is the principal inventor of ThromboLUX® and the founder of LightIntegra Technology. Elisabeth has over twenty years of research experience devoting her career to understanding platelet function and the application of dynamic light scattering. She was a scientist with Canadian Blood Services and holds the position of Adjunct Scientist with CBS since 2010. Elisabeth also holds a position as Clinical Associate Professor with the University of British Columbia and is an active member of a number of organizations with a focus on blood transfusion such as AABB, CSTM, ISTH and the UBC CBR. She received her Ph.D. in physical chemistry from the Karl-Franzens University in Graz, Austria.


Bill Dubiel

Bill brings more than 28 years of experience in the medical device industry, and extensive commercial knowledge, to LightIntegra. He has held senior level positions at Personal Genome Diagnostics, CyVek, Ventana, Roche, Bayer and Chiron Diagonstics. During his career he has successfully launched 5 uniquely innovative technologies in the clinical and life science segment. Bill has an excellent track record in bringing rapid success to start-ups. He successfully exited a biotechnology start-up company for over $105 million within 6 months of the product launch. He as also assisted in the commercial launch of two other medical device start-ups, collectively gaining over $80 million in series B funding. 


Paul Geyer

Paul has been actively involved in the cardiac surgery and interventional cardiology markets for the past twenty years. In 1991 he founded Mitroflow International Inc., and as President and CEO, he grew the company from 9 to 125 employees as it successfully commercialized various tissue heart valve products. In 1999 the company was named one of BC’s “50 Fastest Growing Companies”, and was sold to Sulzer Medica for over $50 million. Paul received the 1998 Entrepreneur of the Year award from the Richmond Chamber of Commerce, and in 1999 was named one of the “40 under 40” business people in British Columbia by Business in Vancouver. Paul went on to found Medical Venture Corp. (Now Neovasc Inc.), a specialty vascular device company that develops medical devices for the rapidly growing vascular and surgical marketplace. At Medical Ventures, he was responsible for raising over $37 million in equity financing and expanding the company’s product portfolio through internal development and the acquisition of three other companies.

In addition to his role as CEO at LightIntegra, Paul is Chairman at Neovasc, and is an active Angel investor in technology and life science companies. He has served on the Board of Directors of Science World British Columbia since 2003 where he was actively involved in the establishment of a new life sciences gallery called “BodyWorks” and currently holds the position of Chairman. Paul has also established a private foundation, the PNG Enterprise foundation, which is actively involved in projects supporting a number of different Charitable organizations including World Vision, Red Cross, Salvation Army, local public schools, take-a-hike youth at risk program, Science World and others.

Paul Geyer is a successful Medtech Entrepreneur and experienced Board member. Over the past 20 years Paul founded and led two companies through their growth phase, in one case to a successful private exit and in the other case through growth as a public company with numerous acquisitions. Both companies have grown to be anchor medical device companies in the Vancouver area, employing more than 350 people.

In 1991 he founded Mitroflow International Inc., a tissue heart valve company. Paul grew the company from 9 employees to more than 125 employees in 1999. In 1999 Paul sold Mitroflow to Sulzer Medica, for more than $50 mil. Paul's leadership resulted in Mitroflow growing to more than 200 employees, making it one of the largest medical device companies in the Vancouver area.

In 2001 Paul started Medical Ventures, a new specialty vascular device company where he is currently Chairman of the Board. From its inception to June 2008, Mr. Geyer held the position of CEO at Medical Ventures (now Neovasc) and was responsible for raising over $40 million in Equity financing and growing the company’s product portfolio through internal development and the acquisition of 3 other companies. Neovasc is a public company on the TSX and Nasdaq with a market cap of more than $700mil and continues to grow with operations in both Vancouver and Minneapolis, employing approximately 200 people.

In 2008 Paul began focusing on sharing his expertise to assist other Entrepreneurs to build successful businesses, through his involvement as a mentor or Board member. Mr. Geyer is an active Angel Investor in technology and life science companies. In 2010 Paul was awarded the British Columbia Angel Investor of the year, and over the years has invested over $5mil in start-up businesses. He is an active supporter of the local Angel investment community, donating his time to assist local companies and investors through education programs and direct one-on-one mentoring. He is an active alumnus of the Kappa Sigma Fraternity. In 2011 Paul received the BC Life Sciences Leadership Award.

He is also focused on building the local community through his involvement as a Board member of both the Life Sciences and Technology associations, along with a number of non-profit community based organizations. Paul is actively engaged as a Philanthropist as the Chair of the Board of Social Venture Partners Vancouver. He is also involved in a number of other non-profit organizations including Science World Chairs Council, Entrepreneurship at UBC Board member, Project Somos Children’s Village and other local and International organizations.Paul graduated with a BASc. in Electrical Engineering from the University of British Columbia in 1988 and gained his Professional Engineer status in 1990. He has taken numerous postgraduate courses in Bio-medical Engineering and medical technology and has completed the Canadian Securities Course.


Brent James

Brent was an early employee at MDI Mobile Data International, where he pioneered the marketing of wireless communications into the North American utility industry. Subsequent to MDI, Brent was a co-founder of MDSI Mobile Data Solutions Inc., a leading provider of wireless workforce management solutions in the utilities and telecommunications industries worldwide. MDSI went public on NASDAQ in the late 1990’s, and was recently taken private.

Following MDSI, Brent became the first CEO of Abebooks.com, one of the world’s largest Internet sources of used, rare, and out-of-print books. Abebooks was  sold to Amazon in a transaction that provided healthy returns for founders, employees, and investors.

Brent is currently the President and CEO of Aquila Diagnostic Systems Inc. Aquila is commercializing its patented solutions for point-of-care DNA/RNA diagnostic testing.


Geof Auchinleck

Geof has been involved in the medical device industry since the early 1980s, working on a number of medical device projects ranging from advanced laboratory automation systems to development of the world’s first surgical robot.

In 1997, Geof founded Neoteric Technology Ltd., a company providing systems for managing blood products for transfusion in hospitals. He managed and grew the company until April 2009 when it was sold to Haemonetics Corporation.

Since 1990, Geof has served on the Board of Directors of Vancouver’s Medical Device Development Centre Association, including 22 years as chair.  He also serves on the board of the AceTech Academy for Technology CEOs and as an independent director on the board of two other medical device companies.

Geof studied Engineering Physics at the University of British Columbia and holds 17 US patents on inventions ranging from surgical robotic devices to systems for ensuring safe blood transfusion.


Andrew Booth

Andrew Booth is currently the CFO at STEMCELL Technologies in Vancouver, Canada. STEMCELL is Canada’s largest biotech company and designs, develops, and manufactures products used in cellular research around the world. STEMCELL has direct operations in North America, Europe, Southeast Asia and China. Before taking the role of CFO, Andrew led the formation of the Instrumentation Division at STEMCELL.

Prior to joining STEMCELL, Andrew spent approximately 7 years at General Electric in Koln, Paris, New York, Florence and London in a variety of positions and ending in roles leading Business Development (responsible for mergers, acquisitions, & partnerships) for GE Healthcare’s Europe, Middle East, & Africa business and GE Healthcare’s Life Sciences business. Andrew is also a graduate of GE’s Experienced Commercial Leadership Program.

Andrew did his MBA at INSEAD in France and completed his degree in Engineering Physics at UBC receiving the UBC Outstanding Student Award upon graduation. Andrew co-founded Zaber Technologies which designs, produces and sells micro positioning equipment globally. Andrew also worked for Creo Technologies in Vancouver in product design, product management and business development.

Andrew is currently a director on the Board of Precision Nanosystems, is a recurring mentor for the New Ventures BC business plan competition, and is a member of the fundraising board for Science World in Vancouver. Andrew was named to Business in Vancouver's Top Forty under 40 list in 2012, and he resides in Squamish, BC with his wife Danica and their 4 children.